Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn

  • Posted on January 10, 2025
  • By Financial Times
  • 1 Views
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers
continue reading...

Author
Financial Times

You May Also Like